HTX-034
- Generic Name
- HTX-034
Dose-Escalation Study of HTX-034 Following Bunionectomy
Phase 1
Completed
- Conditions
- Bunions
- Interventions
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Heron Therapeutics
- Target Recruit Count
- 73
- Registration Number
- NCT04398329
- Locations
- 🇺🇸
Endeavor Clinical Trials, LLC, San Antonio, Texas, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath